Sprint Bioscience AB
XMUN:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
M
|
Matador Resources Co
F:7MR
|
US |
|
N
|
Naspers Ltd
JSE:NPN
|
ZA |
|
P
|
Publicis Groupe SA
XMUN:PU4
|
FR |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
D
|
Danone SA
SIX:DAN
|
FR |
|
Rothschild & Co SCA
PAR:ROTH
|
FR |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
|
A
|
Avery Dennison Corp
DUS:AV3
|
US |
|
U
|
Universal Health Services Inc
SWB:UHS
|
US |
|
C
|
Cheniere Energy Inc
XMUN:CHQ1
|
US |
|
China Coal Energy Co Ltd
OTC:CCOZF
|
CN |
|
W
|
Worley Ltd
F:WF9
|
AU |
|
Summit Materials Inc
NYSE:SUM
|
US |
|
I
|
IHS Markit Ltd
F:0M3
|
UK |
|
F
|
Fluent Inc
F:7TM
|
US |
|
L
|
LY Corp
XMUN:YOJ
|
JP |
|
W
|
Worley Ltd
OTC:WYGPY
|
AU |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
Matas A/S
CSE:MATAS
|
DK |
Wall St Price Targets
5JA1 Price Targets Summary
Sprint Bioscience AB
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.464 EUR with a low forecast of 0.46 EUR and a high forecast of 0.478 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5JA1's stock price target?
Price Target
0.464
EUR
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.464 EUR with a low forecast of 0.46 EUR and a high forecast of 0.478 EUR.
What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%
Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.
What is the Gross Profit forecast for Sprint Bioscience AB?
Projected CAGR
-24%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 2 years is -24%.
What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%
The compound annual growth rate for Operating Income over the next 3 years is -73%.
What is the Pre-Tax Income forecast for Sprint Bioscience AB?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 2 years is -20%.
What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-15%
The compound annual growth rate for Net Income over the next 2 years is -15%.
